Pfizer (PFE) Other Non-Current Liabilities (2009 - 2026)
Pfizer (PFE) recorded Other Non-Current Liabilities of $14.78 billion in Q2 2026, up 6.1% from $13.93 billion a year earlier and up 4.1% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Pfizer reported Other Non-Current Liabilities of $14.73 billion, up 4.1% from FY2024.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 5.0% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $14.15 billion in FY2024 (-14.4%), $16.54 billion in FY2023 (+25.5%), $13.18 billion in FY2022 (+16.3%) and $11.33 billion in FY2021 (-2.0%).
- The Q2 2026 figure is the highest quarterly Other Non-Current Liabilities since Q3 2024.
- On a year-over-year basis, Other Non-Current Liabilities has increased for three consecutive quarters, with an average decline of 5.1% over the last seven quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 25.5% in Q4 2023, against a decline of 14.4% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.2 billion (Q1 2026), $14.73 billion (Q4 2025) and $13.61 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 14.78 Bn |
| Mar 29, 2026 | 14.20 Bn |
| Dec 31, 2025 | 14.73 Bn |
| Sep 28, 2025 | 13.61 Bn |
| Jun 29, 2025 | 13.93 Bn |
| Mar 30, 2025 | 13.30 Bn |
| Dec 31, 2024 | 14.15 Bn |
| Sep 29, 2024 | 15.57 Bn |
| Jun 30, 2024 | 16.10 Bn |
| Mar 31, 2024 | 15.12 Bn |
| Dec 31, 2023 | 16.54 Bn |
| Jul 2, 2023 | 13.40 Bn |
| Apr 2, 2023 | 13.01 Bn |
| Dec 31, 2022 | 13.18 Bn |
| Jul 3, 2022 | 11.31 Bn |
| Apr 3, 2022 | 11.57 Bn |
| Dec 31, 2021 | 11.33 Bn |
| Oct 3, 2021 | 11.34 Bn |
| Jul 4, 2021 | 11.26 Bn |
| Apr 4, 2021 | 11.76 Bn |
API Access
Pfizer Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();